A multicenter retrospective study of patients with pulmonary hypertension transitioned from inhaled to oral treprostinil
Oral treprostinil has recently been shown to delay disease progression in patients with pulmonary arterial hypertension in a long-term outcomes study. The potential advantages of an oral formulation have resulted in patients transitioning from inhaled to oral treprostinil. The current study reports...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2021-03-01
|
| Series: | Pulmonary Circulation |
| Online Access: | https://doi.org/10.1177/2045894021998203 |